Wednesday, 23 October 2013

London Researcher Dr. Shawn Li Receives CCS Innovation Grant to Study Ways to Overcome Chemotherapy Resistance in Breast Cancer

Dr. Shawn Li has received a CCS Innovation Grant to study ways to overcome chemotherapy resistance in breast cancer. The focus of Dr. Li's work is the "triple negative" cancer cell that test negative for three things: estrogen receptors, progesterone receptors and HER2 overexpression. Dr Li, a professor in the Department of Biochemistry at Western University, is studying a biochemical reaction that plays a critical role in the death of triple-negative breast cancer cells and is also involved in chemotherapy resistance. His new project will study how two proteins –Numb and Set8—interact in this reaction and look for compounds that could serve as the first targeted treatments for triple-negative breast cancers.Read more.

Thursday, 17 October 2013

Taking it easy - the opposite for breast cancer survivors

This month in our Londoner article Dr. Tracy Sexton, radiation oncologist at the London Regional Cancer Program, and Stefanie De Jesus, PhD Candidate at Western University discuss some of the research being done around the impact of exercise on the recovery of breast cancer patients. Our thanks to the Londoner for their continuing support in publishing our monthly column on the progress and promise in Cancer Research, and to the researchers and research trainees for taking the time to write the articles on the great work that is going on today in London.